expressions of cxcl12cxcr4 in oral premalignant and malignant lesions表达式的cxcl12cxcr4口腔癌变前的和恶性病变.pdfVIP

Hindawi Publishing Corporation Mediators of Inflammation Volume 2012, Article ID 516395, 5 pages doi:10.1155/2012/516395 Clinical Study Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions Juan Xia, Na Chen, Yun Hong, Xiaobing Chen, Xiaoan Tao, Bin Cheng, and Yulei Huang Department of Oral Medicine, Guanghua School of Stomatology and Institute of Stomatological Research, Sun Yat-Sen University, No. 56, Lingyuanxi Road, Guangdong, Guangzhou 510055, China Correspondence should be addressed to Juan Xia, juanshar@ Received 25 August 2011; Revised 28 October 2011; Accepted 29 October 2011 Academic Editor: Teresa Zelante Copyright © 2012 Juan Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. The chemokine receptor CXCR4 and its ligand CXCL12 have been suggested to play important roles in the initiation or progression of cancers. The goal of the present study was to investigate alterations of CXCL12/CXCR4 in oral premalignant lesions and oral squamous cell carcinoma (OSCC). Methods. In 13 normal oral epithelia, 24 dysplastic oral leukoplakia (OLK), and 40 OSCC specimens, expressions of CXCL12 and CXCR4 were evaluated by immunohistochemistry. Results. CXCR4 was expressed in 37.5% of OLK and 60% of OSCC. CXCL12 was detected in 50% of OLK and 62.5% of OSCC. In OLK, CXCR4 positive ratio showed no significant difference from normal epithelia, but the CXCL12 positive ratio was significantly higher. Significant relationship between CXCL12 and CXCR4 was found both in OLK and OSCC. Conclusion. Our results indicated that CXCL12/CXCR4 axis may play roles from early steps of oral malignant tra